Perico, Norberto <br/><br/>
V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.  [electronic resource] 

 -  Kidney international  Nov 2009 
 - 960-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1755 
<br/><br/><label>Standard No.: </label>10.1038/ki.2009.267  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II Type 1 Receptor Blockers--pharmacology<br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Animals<br/>Antidiuretic Hormone Receptor Antagonists<br/>Benzazepines--blood<br/>Biomarkers--blood<br/>Blood Pressure--drug effects<br/>Body Weight--drug effects<br/>Chronic Disease<br/>Disease Models, Animal<br/>Disease Progression<br/>Diuresis--drug effects<br/>Drinking--drug effects<br/>Drug Therapy, Combination<br/>Eating--drug effects<br/>Enalapril--pharmacology<br/>Hormone Antagonists--blood<br/>Kidney--drug effects<br/>Kidney Diseases--drug therapy<br/>Losartan--pharmacology<br/>Male<br/>Nephrectomy<br/>Proteinuria--drug therapy<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Vasopressin--metabolism<br/>Renin-Angiotensin System--drug effects<br/>Spiro Compounds--blood<br/>Time Factors